Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Mesothelioma
Closed
Phase 2
This trial is looking at a drug called nintedanib after chemotherapy for pleural mesothelioma.
Mesothelioma is a type of cancer that can develop in the lining that covers the outer surface of the lungs. This is called pleural mesothelioma.
Recruitment start: 5 February 2018
Recruitment end: 3 February 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sanjay Popat
European Organisation for Research and Treatment of Cancer (EORTC)
Last reviewed: 22 Jun 2023
CRUK internal database number: 16268